Wally
Wally Raises $25M Series A for Subscription Dental Care
Wally announced $25M in Series A financing on October 7, 2026. Wally announced $25 million in Series A funding led by Maveron and says it plans to expand from 15 to 100 locations by the end of 2027.
Round details
The financing includes backing from Maveron, Bling Capital, Jack Abraham. The company did not publish a valuation with the announcement.
- Round: Series A
- Capital announced: $25M
How the company plans to use the capital
Wally said it plans to use the new capital to bring its subscription oral care model to new metropolitan hubs in Washington DC, Atlanta, Austin, and Miami, where it is establishing waitlists. The release also says Wally plans to expand from 15 to 100 locations by the end of 2027 and is hiring clinicians and operational leaders. It did not give a dollar breakdown.
Why this matters for GTM teams
Wally says it recently surpassed 50,000 members on a $249 annual membership that includes unlimited cleanings and diagnostics with no insurance required.
Fresh capital is often an operational signal rather than a buying signal by itself. Teams should validate the company’s hiring pattern, product launches, geographic expansion, and technology priorities before choosing the message and timing of outreach.
Source and methodology
This report is based on the company’s announcement and records the disclosed amount, round, investors, location, and stated use of funds. SalesTools Research does not estimate undisclosed valuation or revenue figures.
Primary source: Wally Series A announcement.
Company Info
Investors (3)
Share
Related Reports
Wabi Raises $55M at $1.25B Valuation in IVP-Led Funding
Wabi announced $55 million in funding led by IVP at a $1.25 billion valuation, which it said will support continued product development and expansion.
StimCardio Raises $30M Series A for Wearable AF Therapeutic
StimCardio announced the closing of an oversubscribed $30 million Series A led by Metis Medtech, expected to fund the company through its planned NeuroPulse 2 pivotal study and preparation for an FDA De Novo submission.
Casap Raises $56M Series B for AI Agents in Financial Services
Casap raised a $56 million Series B led by Base10 Partners, with Experian and Synchrony participating, to advance its AI agent platform for financial services.
Turn your sales ideas into reality today
Pick a plan and go live today. Change or cancel any time.
Get started


